Treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy for prostate cancer
Authors:
- 25 February 2007
- journal article
- Published by Springer Nature in International Journal of Clinical Oncology
- Vol. 12 (1) , 37-41
Abstract
The indications for and the efficacy of radiation therapy after radical operation for patients with prostate cancer are not clear. We analyzed the treatment results of adjuvant radiotherapy and salvage radiotherapy after radical prostatectomy.Between September 1997 and November 2004, 57 patients received adjuvant radiotherapy or salvage radiotherapy after radical prostatectomy. Fifteen patients received radiation therapy because of positive margins and/or extracapsular invasion in surgical specimens (adjuvant group). Forty-two patients received radiation therapy because of rising prostate-specific antigen (PSA) during follow-up (salvage group). Radiation therapy was delivered to the fossa of the prostate +/- seminal vesicles by a three-dimensional (3-D) conformal technique to a total dose of 60-66 Gy (median, 60 Gy). Biochemical control was defined as the maintenance of a PSA level of less than 0.2 ng/ml.The median follow-up period after radiation therapy was 33 months (range, 12-98 months). Three-year biochemical control rates were 87% for the adjuvant group and 61% for the salvage group. For patients in the salvage group treated without hormone therapy, the preradiation PSA value was the most significant factor for the biochemical control rate. The 3-year biochemical control rate was 93% in patients whose preradiation PSA was 0.5 ng/ml or less and 29% in patients whose preradiation PSA was more than 0.5 ng/ml. No severe adverse effects (equal to or more than grade 3) were seen in treated patients.Radiation therapy after radical prostatectomy seemed to be effective for adjuvant therapy and for salvage therapy in patients with a preradiation PSA of 0.5 ng/ml or less. Also, radiation to the fossa of the prostate +/- seminal vesicles, to a total dose of 60-66 Gy, using a three-dimensional (3-D) conformal technique, seemed to be safe.Keywords
This publication has 20 references indexed in Scilit:
- Parameters for Treatment Decisions for Salvage Radiation TherapyJournal of Clinical Oncology, 2005
- Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate post-operative irradiation? (EORTC trial 22911)European Journal of Cancer, 2005
- Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic featuresInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Postoperative radiotherapy in 423 patients with pT3N0 prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosisUrology, 1999
- The efficacy of early adjuvant radiation therapy for pt3n0 prostate cancer: a matched-pair analysisInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- State T1–2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancerUrology, 1996